Australian Study: Vaping Three Times More Effective Than Traditional Therapies for Quitting Smoking, Long-Term Health Risks Unclear

Jul.17.2025
Australian Study: Vaping Three Times More Effective Than Traditional Therapies for Quitting Smoking, Long-Term Health Risks Unclear
A new Australian study found flavored nicotine e-cigarettes are three times more effective than gum or lozenges for quitting smoking. The trial of 1,000 smokers on government support showed higher quit rates with vaping, but long-term health risks remain unclear.

Key Points:

 

·A study in Australia has found that the success rate of quitting smoking using e-cigarettes is three times higher than traditional nicotine replacement therapy.

 

·The study involved over 1000 smokers, with 28% of the e-cigarette group remaining smoke-free after six months, compared to less than 10% in the traditional therapy group. 

 

·The study emphasizes the short-term effectiveness of e-cigarettes, but further research is needed to understand their long-term health impacts.

 


【2Firsts News Flash】According to a report by UPI on July 14th, a new Australian study suggests that e-cigarettes may be more effective in helping people quit smoking compared to traditional nicotine replacement therapy.

 

Researchers reported in the Annals of Internal Medicine that individuals using flavored e-cigarette devices containing nicotine had a three times higher smoking cessation rate within six months compared to those using nicotine gum or lozenges.

 

“Nicotine vapor products are more effective in smoking cessation compared to nicotine replacement therapy.”

 

The research team led by Associate Professor Ryan Courtney of the National Drug and Alcohol Research Centre at the University of New South Wales in Australia wrote.

 

In order to conduct this study, researchers recruited over 1000 Australians receiving government assistance and randomly assigned them to either the e-cigarette group or the nicotine replacement group. All participants were interested in trying to quit smoking.

 

The e-cigarette group received an eight-week supply of tobacco, mint, or fruit flavored e-liquid, while the nicotine replacement group opted for an eight-week supply of gum or lozenges.

 

Researchers stated that all participants also received automated text messages for five weeks, which provided them with behavioral support for their smoking cessation attempts.

 

A study found that after six months, over 28% of individuals in the e-cigarette group remained smoke-free, while slightly less than 10% of individuals in the nicotine gum or lozenge group remained smoke-free.

 

“In the current trial, it was found that for disadvantaged populations, flavored nicotine vaping products combined with minimal text-based support were more effective than nicotine replacement therapy gum or lozenges.”

 

Researchers have reached a conclusion.

 

However, researchers point out that further research is needed to ensure that people can maintain a smoke-free status in the long term when using e-cigarette devices.

 

Researchers added that it is still not clear whether people are simply replacing one health risk with another.

 

“Despite current evidence suggesting that switching completely from smoking cigarettes to e-cigarettes can reduce health risks, the long-term health effects of e-cigarettes are largely unknown, and there is data indicating that e-cigarettes may impact cardiovascular health.”

 

The researchers wrote.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Product | 20ml E-liquid, Dual Modes with Up to 60,000 Puffs, Uwell Launches VALAYA AMP 60K Vape in the U.S.
Product | 20ml E-liquid, Dual Modes with Up to 60,000 Puffs, Uwell Launches VALAYA AMP 60K Vape in the U.S.
Uwell has recently launched its new disposable vape, the VALAYA AMP 60K, on its official website. The device features 20ml of pre-filled e-liquid and is rated for up to approximately 60,000 puffs. It is equipped with a 950mAh rechargeable battery and a 0.6Ω dual mesh coil. The product is now available through select online channels in the United States, with a listed price of $19.99.
Apr.09 by 2FIRSTS.ai
PMI U.S. Says Dothan Factory Closure Reflects Focus on Smoke-Free Business Strategy
PMI U.S. Says Dothan Factory Closure Reflects Focus on Smoke-Free Business Strategy
Philip Morris International U.S. (PMI U.S.) announced that it will close the Swedish Match cigar manufacturing facility on Columbia Highway in Dothan, Alabama. The company said the decision reflects its need to maintain focus on offering reduced-risk, FDA-authorized smoke-free products to legal-aged adult nicotine users in the United States to help them move away from combustible cigarettes.
Mar.30 by 2FIRSTS.ai
BAT Malaysia Launches Workforce Exercise to Improve Efficiency and Align With Future Business Direction
BAT Malaysia Launches Workforce Exercise to Improve Efficiency and Align With Future Business Direction
British American Tobacco Malaysia has announced a workforce optimisation exercise aimed at streamlining operations ahead of a major shift in its distribution strategy.
Apr.01 by 2FIRSTS.ai
Bulgaria’s Disposable Vape Ban Receives Formal Approval From the European Commission
Bulgaria’s Disposable Vape Ban Receives Formal Approval From the European Commission
The European Commission has formally published its decision approving Bulgarian legislation banning the placing on the market, offering and sale of disposable e-cigarettes.
Mar.17 by 2FIRSTS.ai
BAT Rothmans Upgrades neo™ Boost for glo™ HYPER Series
BAT Rothmans Upgrades neo™ Boost for glo™ HYPER Series
BAT Rothmans said on April 13 that its heated tobacco brand glo™ will launch an upgraded version of neo™ Boost, the dedicated stick for the HYPER series. The company said the refresh focuses on strengthening freshness and cooling sensations to improve the overall user experience.
Apr.14 by 2FIRSTS.ai
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
From myblu to Zone: Imperial Brands Refocuses NGP Strategy in HY26
mperial Brands’ HY26 results point to a more selective NGP transition. The company is using cash flow from traditional tobacco to fund targeted investments in modern oral nicotine, heated tobacco and reusable vaping systems. Its decision to exit the legacy myblu vaping business in the U.S., while expanding Zone nicotine pouches. In Europe, Imperial’s NGP growth is being driven by a multi-category portfolio including blu, Pulze and Zone/Skruf.
Special Report
May.12